NCT01039467

A Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing

Study of a Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 385 (actual)
• Sponsor: Medtronic Cardiac Rhythm and Heart Failure · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The COMPARE-Adapta study is a randomized, multi-center, prospective study conducted in China. The purpose of the study is to compare the ability of Search AV™+ and Managed Ventricular Pacing® (MVP®) to reduce ventricular pacing in dual chamber pacemaker-indicated patients. The COMPARE-Adapta study will also observe atrial fibrillation (AF) burden as demonstrated by Cardiac Compass® and the clinical profile Adapta® pacemaker patients.

Detailed description

Recent studies suggest that chronic right ventricular pacing is associated with a variety of adverse effects in patients, particularly those with intact or intermittent atrioventricular (AV) conduction. Medtronic Adapta® pacemakers include Managed Ventricular Pacing®, a pacing mode designed to promote intrinsic conduction, and also Search AV™+, a feature designed to reduce unnecessary ventricular pacing in patients with intact or intermittent AV conduction.

Conditions

• Bradycardia

Interventions

Type	Name	Description
DEVICE	Medtronic Adapta Dual Chamber Pacemaker	Medtronic Adapta Dual Chamber Pacemaker

Timeline

• Start date: 2009-06-01
• Primary completion: 2014-04-01
• Completion: 2014-04-01
• First posted: 2009-12-25
• Last updated: 2020-02-05
• Results posted: 2020-02-05

Locations

30 sites across 1 country: China